The change in the company name merely reflects a change in business structure from a corporation to a limited liability company.
We provide consulting services to pharmaceutical and biotechnology companies for clinical development of treatments mainly in the areas of rheumatology and autoimmune diseases and also across a spectrum of indications, including those in oncology. For startup companies we advise on the transition from nonclinical companies moving into clinical development.
The pharmaceutical industry faces increasing challenges.
Competition, regulatory requirements, and costs have increased, while the rate of new products coming to market has decreased.
Problems in clinical development include:
- Choosing the wrong indication

